Development of a Clinical Risk Stratification for Patients with Newly Diagnosed Multiple Myeloma

被引：0
|
作者：
Mao, Xuehan [1 ,2 ]
Xu, Yan [3 ]
Yan, Yuting [2 ,4 ]
Liu, Jiahui [2 ,4 ]
Fan, Huishou [2 ,4 ]
Sui, Weiwei [1 ,2 ]
Deng, Shuhui [5 ]
Li, Zengjun [2 ,6 ]
Qiu, Lugui [2 ,4 ]
An, Gang [2 ,6 ]
机构：
[1] Chinese Acad Med Sci, Tianjin, Peoples R China
[2] Peking Union Med Coll, Tianjin, Peoples R China
[3] Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China
[4] Chinese Acad Med Sci, Inst Hematol Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin, Peoples R China
[5] Chinese Acad Med Sci, Inst Hematol Blood & Dis Hosp, Tianjin, Peoples R China
[6] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-125044
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4363
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma
    Tsai, Chun-Kuang
    Yeh, Chiu-Mei
    Hsu, Te-Lin
    Li, Chia-Ju
    Tin, Chian
    Hsiao, Liang-Tsai
    Liu, Yao-Chung
    Wang, Hao-Yuan
    Ko, Po-Shen
    Chen, Po-Min
    Liu, Jin-Hwang
    Gau, Jyh-Pyng
    Liu, Chia-Jen
    SUPPORTIVE CARE IN CANCER, 2021, 29 (07) : 3991 - 3999
  • [22] Risk and Incidence of Venous Thromboembolism in Newly Diagnosed Multiple Myeloma Patients
    Nabar, Leeladhar
    Khan, Hamza
    Nair, Aditya
    Mishra, Dhyey
    Shah, Jash
    Lalwani, Devansh
    Talati, Shriraj
    Tembhare, Prashant
    Nayak, Lingaraj
    Shetty, Alok
    Rajpal, Sweta
    Chatterjee, Gaurav
    Khan, Ajmat
    Mirgh, Sumeet
    Jindal, Nishant
    Gokarn, Anant
    Punatar, Sachin
    Jain, Hasmukh
    Patkar, Nikhil
    Shetty, Dhanlaxmi
    Subramanian, Papagudi
    Gujral, Sumeet
    Bagal, Bhausaheb
    Sengar, Manju
    Khattry, Navin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S121 - S121
  • [23] Determination of the individual infection risk for newly diagnosed patients with multiple myeloma
    Kaebisch, E.
    Heck, C.
    Frentsch, M.
    Blau, I. -W
    Nogai, A.
    Bullinger, L.
    Na, I. -K
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 48 - 48
  • [24] The Clinical Relevance of Selected Cytokines in Newly Diagnosed Multiple Myeloma Patients
    Mielnik, Michal
    Szudy-Szczyrek, Aneta
    Homa-Mlak, Iwona
    Mlak, Radoslaw
    Podgajna-Mielnik, Martyna
    Goracy, Aneta
    Malecka-Massalska, Teresa
    Hus, Marek
    BIOMEDICINES, 2023, 11 (11)
  • [25] Clinical relevance of PET/CT in patients with newly diagnosed multiple myeloma
    Wang, Chaoyu
    Wu, Ling
    Sun, Chengtao
    Zhang, Yizhuo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (02): : 619 - 627
  • [26] Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma
    Mellors, Patrick W.
    Binder, Moritz
    Ketterling, Rhett P.
    Greipp, Patricia T.
    Baughn, Linda B.
    Peterson, Jess F.
    Jevremovic, Dragan
    Pearce, Kathryn E.
    Buadi, Francis K.
    Lacy, Martha Q.
    Gertz, Morie A.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Kapoor, Prashant
    Gonsalves, Wilson, I
    Hwa, Yi L.
    Fonder, Amie
    Hobbs, Miriam
    Kourelis, Taxiarchis
    Warsame, Rahma
    Lust, John A.
    Leung, Nelson
    Go, Ronald S.
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    BLOOD ADVANCES, 2020, 4 (10) : 2236 - 2244
  • [27] Machine learning assisted risk stratification of newly diagnosed multiple myeloma with respect to the VRd treatment
    Koo, Jamin
    Choi, Gyucheol
    Park, Sung-Soo
    Byun, Ja Min
    Lim, Sungwon
    Lee, Jong Cheol
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S100 - S101
  • [28] Oprozomib in patients with newly diagnosed multiple myeloma
    Hari, Parameswaran
    Matous, Jeffrey V.
    Voorhees, Peter M.
    Shain, Kenneth H.
    Obreja, Mihaela
    Frye, John
    Fujii, Hisaki
    Jakubowiak, Andrzej J.
    Rossi, Davide
    Sonneveld, Pieter
    BLOOD CANCER JOURNAL, 2019, 9 (9)
  • [29] Oprozomib in patients with newly diagnosed multiple myeloma
    Parameswaran Hari
    Jeffrey V. Matous
    Peter M. Voorhees
    Kenneth H. Shain
    Mihaela Obreja
    John Frye
    Hisaki Fujii
    Andrzej J. Jakubowiak
    Davide Rossi
    Pieter Sonneveld
    Blood Cancer Journal, 9
  • [30] Significance of Modified Risk Stratification Msmart 3.0 and Autologous Stem Cell Transplantation for Patients with Newly Diagnosed Multiple Myeloma
    Garifullin, Andrey
    Voloshin, Sergei
    Shuvaev, Vasily
    Martynkevich, Irina
    Kleina, Elizaveta
    Chechetkin, Alexander
    Bessmeltcev, Stanislav
    Kuzyaeva, Anastasiya
    Hmidt, Alexander S.
    Kuvshinov, Alexey
    Pavlova, Irina
    BLOOD, 2019, 134
12345